Bisphenol A and Muscle Insulin Sensitivity

Completed · Not applicable · Has a placebo group

Conditions studied: Insulin Sensitivity, Glucose Metabolism Disorders, Microtia

In brief

This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.

Key facts

Study ID

NCT03771066

Run by

California Polytechnic State University-San Luis Obispo

People needed

40

Starts

2019-01-01

Expected to finish

2023-12-31

Last updated by the study team

2024-07-08

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• non-dieting
• sedentary (≤3 hour/week of aerobic exercise)
• normal-weight (BMI = 18.5 to 24.9 kg/m2)
• weight-stable for the previous 6 months
• free of any metabolic or chronic disease
• non-smoking, and sedentary

You may not qualify if…

• Hemoglobin A1C based on the American Diabetes Association guidelines of 5.7 to 6.4% (Prediabetes) or >6.4% (Diabetes)
• impaired glucose tolerance
• type 1 diabetes
• type 2 diabetes
• colitis or any inflammatory bowel condition
• neurologic or psychiatric conditions
• smoking
• special diets (e.g. vegetarian, low-carbohydrate, Paleolithic, etc.)
• pregnant women or women trying to become pregnant

Where it is running

• California Polytechnic State University — San Luis Obispo, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.